Nanoform Q2 report: All business targets for 2024 on track
Company Announcement Nanoform Q2 report: All business targets for 2024…
Company Announcement Nanoform Q2 report: All business targets for 2024…
Press release Nanoform Finland Plc August 16, 2024 11:00 a.m.…
Press release Nanoform Finland Plc August 15, 2024 08:10 a.m.…
Company release Nanoform Finland Plc June 14, 2024 17.01 Finnish…
Company release Nanoform Finland Plc June 14, 2024 17.01 Finnish…
Company release Nanoform Finland Plc June 14, 2024 17.01 Finnish…
Company release Nanoform Finland Plc June 14, 2024 17.01 Finnish…
Company release Nanoform Finland Plc June 14, 2024 17:00 Finnish…
Company Announcement Nanoform Finland Plc May 30, 2024 08:10 a.m.…
Company Release Nanoform Finland Plc May 29, 2024 12.30 Finnish…
Company Release Nanoform Finland Plc May 29, 2024 12.30 Finnish…
Press release Nanoform Finland Plc May 16, 2024 11:00 a.m.…
Press Release Nanoform Finland Plc May 7, 2024 09.10 EEST…
Company Release Nanoform Finland Plc April 26, 2024 11.00 Finnish…
Company Release Nanoform Finland Plc April 25, 2024 17.00 Finnish…
Inside information Nanoform Finland Plc April 24, 2024 22.50 Finnish…
Inside information Nanoform Finland Plc April 24, 2024 18.31 Finnish…
Company release Nanoform Finland Plc April 16, 2024 13.50 Finnish…
Company release Nanoform Finland Plc April 16, 2024 13.40 Finnish…
Press Release Nanoform Finland Plc April 11, 2024 09.00 EEST…
Press release Nanoform Finland Plc April 9, 2024 09.00 EEST…
Company release Nanoform Finland Plc April 8, 2024 09.00 Finnish…
Company release Nanoform Finland Plc March 26, 2024 19.30 Finnish…
Notice to the Annual General Meeting of NANOFORM FINLAND Plc…
Kutsu Nanoform Finland Oyj:n varsinaiseen yhtiökokoukseen Nanoform Finland Oyj:n (”Yhtiö”)…
Company release Nanoform Finland Plc March 12, 2024 18.00 Finnish…
Company release Nanoform Finland Plc March 6, 2024 08.30 Finnish…
Company release Nanoform Finland Plc March 6, 2024 08.30 Finnish…
Company release Nanoform Finland Plc March 6, 2024 08.30 Finnish…
Company release Nanoform Finland Plc March 6, 2024 08.30 Finnish…
Press Release Nanoform Finland Plc February 29, 2024 08:11 a.m.…
Company Announcement Nanoform Finland Plc February 29, 2024 08:10 a.m.…
Press release Nanoform Finland Plc February 16, 2024 11:00 a.m.…
Inside information Nanoform Finland Plc February 15, 2024 12:45 Finnish…
Inside information Nanoform Finland Plc January 26th, 2024 11:20 Finnish…
Company release Nanoform Finland Plc January 10, 2024 23.00 Finnish…
Company release Nanoform Finland Plc January 10, 2024 23.00 Finnish…
Company release Nanoform Finland Plc January 10, 2024 23.00 Finnish…
Company release Nanoform Finland Plc January 10, 2024 23.00 Finnish…
Company release Nanoform Finland Plc January 10, 2024 23.00 Finnish…
Company release Nanoform Finland Plc January 10, 2024 23.00 Finnish…
Company release Nanoform Finland Plc January 10, 2024 23.00 Finnish…
Company release Nanoform Finland Plc January 10, 2024 23:00 Finnish…
Press release Nanoform Finland Plc January 5, 2023 08:10 Finnish…
Company release Nanoform Finland Plc December 18, 2023 16.00 Finnish…
Company release Nanoform Finland Plc December 5, 2023 18.00 Finnish…
Company release Nanoform Finland Plc November 29, 2023 09.00 Finnish…
Company release Nanoform Finland Plc November 29, 2023 09.00 Finnish…
Company release Nanoform Finland Plc November 29, 2023 09.00 Finnish…
Company release Nanoform Finland Plc November 29, 2023 09.00 Finnish…
Company Announcement Nanoform Finland Plc November 22, 2023 08:10 a.m.…
Press release Nanoform Finland Plc November 8, 2023 11:00 a.m.…
Press release Nanoform Finland Plc October 23, 2023 08:10 Finnish…
Press release Nanoform Finland Plc October 19, 2023 12:15 Finnish…
Company release Nanoform Finland Plc September 13, 2023 17:30 Finnish…
Company release Nanoform Finland Plc September 13, 2023 17:30 Finnish…
Company release Nanoform Finland Plc September 13, 2023 17:30 Finnish…
Company release Nanoform Finland Plc September 13, 2023 17:30 Finnish…
Company release Nanoform Finland Plc September 13, 2023 17:30 Finnish…
Company release Nanoform Finland Plc September 13, 2023 17:30 Finnish…
Company release Nanoform Finland Plc September 12, 2023 4:30 p.m.…
Company release Nanoform Finland Plc August 29, 2023 18:10 Finnish…
Company release Nanoform Finland Plc August 29, 2023 18:10 Finnish…
Company release Nanoform Finland Plc August 29, 2023 18:10 Finnish…
Company release Nanoform Finland Plc August 29, 2023 18:10 Finnish…
Company Announcement Nanoform Finland Plc August 24, 2023 08:10 a.m.…
Press release Nanoform Finland Plc August 10, 2023 11:00 a.m.…
Press release Nanoform Finland Plc June 15, 2023 08:10 a.m.…
Company release Nanoform Finland Plc May 31, 2023 09:30 Finnish…
Company release Nanoform Finland Plc May 31, 2023 09:30 Finnish…
Company release Nanoform Finland Plc May 31, 2023 09:30 Finnish…
Company release Nanoform Finland Plc May 31, 2023 09:30 Finnish…
Company Announcement Nanoform Finland Plc May 25, 2023 08:10 a.m.…
Press release Nanoform Finland Plc May 11th, 2023 11:00 a.m.…
Press release Nanoform Finland Plc May 9, 2023 15.00 Finnish…
Company release Nanoform Finland Plc April 12, 2023 15:01 Finnish…
Company release Nanoform Finland Plc April 12, 2023 15.00 Finnish…
Company release Nanoform Finland Plc April 12, 2023 14:00 Finnish…
Company Announcement Nanoform Finland Plc March 15, 2023 15:00 Finnish…
Yhtiötiedote Nanoform Finland Oyj 15 Maaliskuuta, 2023 15:00 Suomen aikaa…
Company Announcement Nanoform Finland Plc February 28, 2023 08:10 a.m.…
Press release Nanoform Finland Plc February 14th, 2023 11:00 a.m.…
Company release Nanoform Finland Plc January 11, 2023 09:00 a.m.…
Company release Nanoform Finland Plc January 11, 2023 09:00 a.m.…
Company release Nanoform Finland Plc December 20th, 2022 15:05 Finnish…
Company release Nanoform Finland Plc December 20th, 2022 15:05 Finnish…
Company Announcement Nanoform Finland Plc December 7th, 2022 11.00 a.m.…
Highly promising in-vivo data for the treatment of glioblastoma multiforme…
Press release Nanoform Finland Plc November 15, 2022 11:00 a.m.…
Company release Nanoform Finland Plc October 27, 2022 19:15 Finnish…
Press release Nanoform Finland Plc October 17, 2022 08:10 a.m.…
We were delighted to gather the entire Nanoform team for…
Company release Nanoform Finland Plc September 7, 2022 18:00 Finnish…
Company release Nanoform Finland Plc September 6, 2022 06:00 p.m.…
Company Announcement Nanoform Finland Plc August 25, 2022 08:10 a.m.…
Press release Nanoform Finland Plc August 10th, 2022 11:00 a.m.…
Press release Nanoform Finland Plc July 14th, 2022 08:10 a.m.…
Company release Nanoform Finland Plc June 13, 2022 18:00 Finnish…
Company release Nanoform Finland Plc June 13, 2022 10:00 a.m.…
Company release Nanoform Finland Plc June 13, 2022 10:00 a.m.…
Company release Nanoform Finland Plc June 13, 2022 10:00 a.m.…
Company release Nanoform Finland Plc June 13, 2022 10:00 a.m.…
Company release Nanoform Finland Plc June 6, 2022 07:30 p.m.…
Company release Nanoform Finland Plc June 6, 2022 07:30 p.m.…
Company release Nanoform Finland Plc June 6, 2022 07:30 p.m.…
Company release Nanoform Finland Plc June 2, 2022 15:45 Finnish…
Company release Nanoform Finland Plc May 30, 2022 12:30 p.m.…
Company Announcement Nanoform Finland Plc May 24, 2022 08:10 a.m.…
Press release Nanoform Finland Plc May 10th, 2022 11:00 a.m.…
Press release Nanoform Finland Plc May 4th, 2022 09:00 a.m.…
Company release Nanoform Finland Plc April 12, 2022 07:05 p.m.…
Company release Nanoform Finland Plc April 12, 2022 07:05 p.m.…
Company release Nanoform Finland Plc April 12, 2022 07:00 p.m.…
Company release Nanoform Finland Plc April 12, 2022 07:00 p.m.…
Company release Nanoform Finland Plc April 12, 2022 12:30 p.m.…
Company release Nanoform Finland Plc March 25, 2022 04.45 p.m.…
New shares of Nanoform registered with the trade register March…
Inside information Nanoform Finland Plc March 22, 2022 23:45 Finnish…
Inside information Nanoform Finland Plc March 22, 2022 18:31 Finnish…
The shareholders of Nanoform Finland Plc (the “Company”) (business ID:…
Nanoform Finland Oyj:n (”Yhtiö”) (Y-tunnus: 2730572-8) osakkeenomistajat kutsutaan varsinaiseen yhtiökokoukseen,…
In today’s pharmaceutical development pipeline, about 70% to 90% of…
Company Announcement Nanoform Finland Plc February 22, 2022 08:10 a.m.…
Press release Nanoform Finland Plc February 8, 20212 11:00 a.m.…
Press release Nanoform Finland Plc February 4, 2022 08:10 a.m.…
Insider information Nanoform Finland Plc January 3, 2022 08:10 a.m.…
Company Announcement Nanoform Finland Plc December 10, 2021 04.45 p.m.…
The strong momentum continues: all near-term business targets for 2021…
Company release Nanoform Finland Plc November 17, 2021 03:00 p.m.…
Press release Nanoform Finland Plc November 17, 2021 10:15 a.m.…
Insider information Nanoform Finland Plc November 15, 2021 05:05 p.m.…
Press release Nanoform Finland Plc November 12, 2021 11:00 a.m.…
Press release Nanoform Finland Plc November 11, 2021 11:00 a.m.…
Our impressive achievements have been recognized across the board, with…
Company Announcement Nanoform Finland Plc October 18, 2021 08:10 a.m.…
Company Announcement Nanoform Finland Plc October 18, 2021 08:10 a.m.…
Company Announcement Nanoform Finland Plc October 18, 2021 08:10 a.m.…
Press release Nanoform Finland Plc September 29, 2021 03:45 p.m.…
Company release Nanoform Finland Plc Sep 24th, 2021 05.30 p.m.…
Press release Nanoform Finland Plc September 23, 2021 14:30 a.m.…
Press release Nanoform Finland Plc September 9, 2021 08:00 a.m.…
Company release Nanoform Finland Plc August 27, 2021 04:30 p.m.…
The strong momentum continues: Additional line capacity, more projects, new…
Press release Nanoform Finland Plc August 12, 2021 11:00 a.m.…
Press release Nanoform Finland Plc August 3, 2021 08:10 a.m.…
Company release Nanoform Finland Plc June 14, 2021 03:00 p.m.…
Company release Nanoform Finland Plc June 11, 2021 06:15 p.m.…
Company release Nanoform Finland Plc June 11, 2021 06:15 p.m.…
Insider information Nanoform Finland Plc June 2, 2021 04:00 p.m.…
Strong momentum continues: three new non-GMP lines commissioned, four new…
Press release Nanoform Finland Plc May 25, 2021 04:00 p.m.…
Company Announcement Nanoform Finland Plc May 20, 2021 09:10 p.m.…
Press release Nanoform Finland Plc May 18, 2021 08:10 a.m.…
Press release Nanoform Finland Plc May 12, 2021 11:00 a.m.…
Company release Nanoform Finland Plc May 11, 2021 08:00 p.m.…
Press release Nanoform Finland Plc April 21st, 2021 08:10 a.m.…
Company release Nanoform Finland Plc April 8, 2021 06.30 p.m.…
Company release Nanoform Finland Plc April 7, 2021 5:30 p.m.…
Company release Nanoform Finland Plc April 6, 2021 06:30 p.m.…
Company release Nanoform Finland Plc April 6, 2021 11:00 a.m.…
Press release Nanoform Finland Plc March 31, 2021 08:10 a.m.…
Press release Nanoform Finland Plc March 22, 2021 08:10 a.m.…
Company Announcement Nanoform Finland Plc March 10, 2021 23:00 Finnish…
Yhtiötiedote Nanoform Finland Oyj 10.3.2021 klo 23.00 Suomen aikaa Kutsu Nanoform…
NOT FOR RELEASE, PUBLICATIONOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, INOR INTO…
Insider information Nanoform Finland Plc March 9, 2021 23:20 Finnish time…
Insider information Nanoform Finland Plc March 9, 2021 18:30 Finnish…
Company Announcement Nanoform Finland Plc February 26, 2021 08:10 a.m.…
Insider information Nanoform Finland Plc February 26, 2021 08:05 a.m.…
Insider information Nanoform Finland Plc February 24, 2021 08:10 a.m.…
Press release Nanoform Finland Plc February 12, 2021 11:00 a.m.…
Press release Nanoform Finland Plc February 9th, 2021 08:10 a.m.…
Insider information Nanoform Finland Plc January 22nd, 2021 at 08.10…
Helsinki, Finland – Finnish Foundation for Share Promotion (Pörssisäätiö/Börsstiftelsen) and…
Insider information Nanoform Finland Plc January 4th, 2021 at 08.10…
Helsinki, Finland – Nasdaq announced today the results of the…
Nanoform has been accepted as a new member of Pharma…
Press Release Nanoform Finland Plc December 21st, 2020 at 09.00…
Inside information Nanoform Finland Plc December 17, 2020 at 7:15 p.m.…
PRESS RELEASE Nanoform Finland Plc December 8th, 2020 06.05 p.m.…
PRESS RELEASE Nanoform Finland Plc December 2nd, 2020 4 p.m.…
COMPANY RELEASE Nanoform Finland Plc, Interim Report January – September…
Inside information Nanoform Finland Plc November 27th, 2020 at 07:50…
PRESS RELEASE Nanoform Finland Plc November 16, 2020 11:00 a.m.…
PRESS RELEASE Nanoform Finland Plc November 11th, 2020 11:00 a.m.…
In Episode 5, Season 2 of the Amplifying Scientific Innovation…
Company Announcement October 23rd, 2020 at 7:00 p.m. Finnish time…
Inside information Nanoform Finland Plc October 20th, 2020 at 5:15…
Nanoform Finland Plc – Manager’s transactions – Goncalo Andrade Nanoform…
COMPANY RELEASE September 2, 2020 at 03:00 p.m. Finnish time …
Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle…
COMPANY RELEASE September 1, 2020 at 1:00 p.m. Finnish time…
COMPANY RELEASE NANOFORM FINLAND PLC, 2020 HALF YEAR FINANCIAL REPORT,…
Nanoform Finland Oyj:n (y-tunnus: 2730572-8) osakkeenomistajat kutsutaan ylimääräiseen yhtiökokoukseen, joka…
The shareholders of Nanoform Finland Plc (business ID: 2730572-8) are…
COMPANY RELEASE August 6, 2020 9:10 am Helsinki time Helsinki,…
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, NEW ZEALAND, AUSTRALIA, JAPAN, HONG KONG, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.
Company Announcement
June 25, 2020 at 4:00 p.m. Finnish time
Press Release June 15, 2020 at 8:00 a.m. Finnish time…
Nanoform Finland Plc – Manager’s transactions – June 10, 2020…
Nanoform Finland Plc – Manager’s transactions – June 10, 2020…
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, NEW ZEALAND, AUSTRALIA, JAPAN, HONG KONG, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.
EI JULKISTETTAVAKSI TAI LEVITETTÄVÄKSI SUORAAN TAI VÄLILLISESTI YHDYSVALTOIHIN, KANADAAN, UUTEEN-SEELANTIIN, AUSTRALIAAN, JAPANIIN, HONGKONGIIN, SINGAPOREEN TAI ETELÄ-AFRIKKAAN TAI MIHINKÄÄN MUUHUN VALTIOON, JOSSA LEVITTÄMINEN TAI JULKISTAMINEN OLISI LAINVASTAISTA.
EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, DIREKT ELLER INDIREKT, I ELLER TILL USA, KANADA, NYA ZEELAND, AUSTRALIEN, JAPAN, HONGKONG, SINGAPORE ELLER SYDAFRIKA ELLER ANNAN JURISDIKTION I VILKEN SÅDAN DISTRIBUTION, OFFENTLIGGÖRANDE ELLER PUBLICERING SKULLE STRIDA MOT GÄLLANDE REGLER.
EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, DIREKT ELLER INDIREKT, I ELLER TILL USA, KANADA, NYA ZEELAND, AUSTRALIEN, JAPAN, HONGKONG, SINGAPORE ELLER SYDAFRIKA ELLER ANNAN JURISDIKTION I VILKEN SÅDAN DISTRIBUTION, OFFENTLIGGÖRANDE ELLER PUBLICERING SKULLE STRIDA MOT GÄLLANDE REGLER.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, NEW ZEALAND, AUSTRALIA, JAPAN, HONG KONG, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.
EI JULKISTETTAVAKSI TAI LEVITETTÄVÄKSI SUORAAN TAI VÄLILLISESTI YHDYSVALTOIHIN, KANADAAN, UUTEEN-SEELANTIIN, AUSTRALIAAN, JAPANIIN, HONGKONGIIN, SINGAPOREEN TAI ETELÄ-AFRIKKAAN TAI MIHINKÄÄN MUUHUN VALTIOON, JOSSA LEVITTÄMINEN TAI JULKISTAMINEN OLISI LAINVASTAISTA.
EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, DIREKT ELLER INDIREKT, I ELLER TILL USA, KANADA, NYA ZEELAND, AUSTRALIEN, JAPAN, HONGKONG, SINGAPORE ELLER SYDAFRIKA ELLER ANNAN JURISDIKTION I VILKEN SÅDAN DISTRIBUTION, OFFENTLIGGÖRANDE ELLER PUBLICERING SKULLE STRIDA MOT GÄLLANDE REGLER.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, NEW ZEALAND, AUSTRALIA, JAPAN, HONG KONG, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.
EI JULKISTETTAVAKSI TAI LEVITETTÄVÄKSI SUORAAN TAI VÄLILLISESTI YHDYSVALTOIHIN, KANADAAN, UUTEEN-SEELANTIIN, AUSTRALIAAN, JAPANIIN, HONGKONGIIN, SINGAPOREEN TAI ETELÄ-AFRIKKAAN TAI MIHINKÄÄN MUUHUN VALTIOON, JOSSA LEVITTÄMINEN TAI JULKISTAMINEN OLISI LAINVASTAISTA.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, NEW ZEALAND, AUSTRALIA, JAPAN, HONG KONG, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.
EI JULKISTETTAVAKSI TAI LEVITETTÄVÄKSI SUORAAN TAI VÄLILLISESTI YHDYSVALTOIHIN, KANADAAN, UUTEEN-SEELANTIIN, AUSTRALIAAN, JAPANIIN, HONGKONGIIN, SINGAPOREEN TAI ETELÄ-AFRIKKAAN TAI MIHINKÄÄN MUUHUN VALTIOON, JOSSA LEVITTÄMINEN TAI JULKISTAMINEN OLISI LAINVASTAISTA.
EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, DIREKT ELLER INDIREKT, I ELLER TILL USA, KANADA, NYA ZEELAND, AUSTRALIEN, JAPAN, HONGKONG, SINGAPORE ELLER SYDAFRIKA ELLER ANNAN JURISDIKTION I VILKEN SÅDAN DISTRIBUTION, OFFENTLIGGÖRANDE ELLER PUBLICERING SKULLE STRIDA MOT GÄLLANDE REGLER.
EI JULKISTETTAVAKSI TAI LEVITETTÄVÄKSI SUORAAN TAI VÄLILLISESTI YHDYSVALTOIHIN, KANADAAN, UUTEEN-SEELANTIIN, AUSTRALIAAN, JAPANIIN, HONGKONGIIN, SINGAPOREEN TAI ETELÄ-AFRIKKAAN TAI MIHINKÄÄN MUUHUN VALTIOON, JOSSA LEVITTÄMINEN TAI JULKISTAMINEN OLISI LAINVASTAISTA.
EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, DIREKT ELLER INDIREKT, I ELLER TILL USA, KANADA, NYA ZEELAND, AUSTRALIEN, JAPAN, HONGKONG, SINGAPORE ELLER SYDAFRIKA ELLER ANNAN JURISDIKTION I VILKEN SÅDAN DISTRIBUTION, OFFENTLIGGÖRANDE ELLER PUBLICERING SKULLE STRIDA MOT GÄLLANDE REGLER.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, NEW ZEALAND, AUSTRALIA, JAPAN, HONG KONG, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.
EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, DIREKT ELLER INDIREKT, I ELLER TILL USA, KANADA, NYA ZEELAND, AUSTRALIEN, JAPAN, HONGKONG, SINGAPORE ELLER SYDAFRIKA ELLER ANNAN JURISDIKTION I VILKEN SÅDAN DISTRIBUTION, OFFENTLIGGÖRANDE ELLER PUBLICERING SKULLE STRIDA MOT GÄLLANDE REGLER.
EI JULKISTETTAVAKSI TAI LEVITETTÄVÄKSI SUORAAN TAI VÄLILLISESTI YHDYSVALTOIHIN, KANADAAN, UUTEEN-SEELANTIIN, AUSTRALIAAN, JAPANIIN, HONGKONGIIN, SINGAPOREEN TAI ETELÄ-AFRIKKAAN TAI MIHINKÄÄN MUUHUN VALTIOON, JOSSA LEVITTÄMINEN TAI JULKISTAMINEN OLISI LAINVASTAISTA.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN…
Nanoform Finland Oyj (“Nanoform” tai “Yhtiö”) julkisti tänään suunnitellun listautumisantinsa…
Nanoform Finland Plc (”Nanoform” eller ”Bolaget”) offentliggjorde i dag teckningskursen…
Nanoform Finland Oyj (“Nanoform” tai “Yhtiö”) julkisti tänään suunnitellun listautumisantinsa…
Nanoform announces a fixed subscription price and publishes a prospectus…
Nanoform harkitsee listautumisantia ja kaksoislistautumista Nasdaq First North Premier Growth…
Nanoform intends to launch an initial public offering and dual…
Nanoform Finland Plc (”Nanoform” eller ”Bolaget”), ett bolag som erbjuder…
Nanoform harkitsee listautumisantia ja kaksoislistautumista Nasdaq First North Premier Growth…
Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine…
Nanoform has appointed Miguel Calado as Chairman of the Board.
The COVID-19 pandemic is evolving rapidly, and we would like to assure our customers, partners, and suppliers that we are diligently monitoring the situation and follow the most up-to-date World Health Organization, EU, and local government guidelines.
Nanoform and Orion Corporation, a Finnish pharmaceutical company, today announced a collaboration to apply Nanoform’s award-winning CESS® technology to new chemical entities.
Nanoform has established Nanoform USA Inc., a wholly owned subsidiary in the US.
Nanoform has filed for GMP status with the Finnish Medicines Agency, FIMEA. The drug substance application for GMP clinical manufacture certification exemplifies its progress and growth in the last 12 months.
Nanoform, an innovative medicine enabling nanotechnology company, has won the Excellence in Pharma Award for Formulation at the prestigious CPhI Pharma Awards.
We are delighted to have been shortlisted as a finalist for the CPhI Award in the Excellence in Pharma: Formulation category.
Nanoform is delighted to announce the initiation of a technology evaluation of Nanoform’s Proprietary CESS Technology across a range of AstraZeneca’s proprietary pharmaceutical products.
Nanoform has appointed Mads Laustsen as a non-executive board member. This appointment will further strengthen the experienced Nanoform board and support the company as it increases its ability to deliver nanonized APIs for global partners across the pipeline from late stage drug discovery to commercial.
Nanoform has appointed Mike Rea as its Strategic Innovation Advisor. The role will involve working closely with Nanoform to maximise the value its proprietary nanonization technology can deliver to pharmaceutical partners and patients globally.
Nanoform has appointed Henri von Haartman as Director of Investor Relations. The newly created role will enrich investor relations as Nanoform seeks to further its shareholder base and continue its international growth, including expansion into the US market.
Nanoform announced the completion of a private placement totaling €10 million, with Ilmarinen Mutual Pension Insurance Company and Mandatum Life Insurance Company (Sampo Group) acting as anchor investors.
Nanoform has unveiled a new brand identity and website. The evolution of Nanoform’s brand reflects how the company is using innovation to transform the pharmaceutical industry and support its global partners as they develop life-changing medicines.
Our CCO, Christian Jones, recently discussed the advantages of our nanonization services with Mike Ward at EBD Group’s BIO-Europe Spring 2019. Watch the Scrip video to learn more:
Nanoform accelerates growth with Director of Project Management appointment Helsinki, Finland – Nanoform, an innovative drug enabling nanotechnology company, will appoint Miguel Cansado as its Director of Project Management.
Nanoform awarded with a Seal of Excellence from the European Commission Helsinki, Finland – Nanoform, an innovative drug enabling nanotechnology company, has received a Seal of Excellence from the European Commission for its “Nanomedicines of Tomorrow” project.
Nanoform strengthens GMP capabilities with Head of Manufacturing appointment Helsinki, Finland – Nanoform, an innovative drug enabling nanotechnology company, has appointed Dr David Rowe as its Head of Manufacturing.
Nanoform strengthens board with appointment of Vice Chairman Helsinki, Finland – Nanoform, an innovative drug enabling nanotechnology company, has announced the appointment of Miguel Calado as Vice Chairman of the Board.
Nanoform, an innovative drug enabling nanotechnology company, has announced significant progress in the construction of its new 600m2 GMP manufacturing plant, located at Cultivator II in Viikki Life Science Park, Finland.
Nanoform, an innovative drug enabling nanotechnology company, has announced the appointment of Prof Jukka Corander as Head of AI.
Nanoform, an innovative drug enabling nanotechnology company, has appointed Dr Niklas Sandler as Chief Technology Officer.
Nanoform, an innovative drug enabling nanotechnology company, has appointed Dr Gonçalo Rebelo de Andrade as Chief of Business Operations.
Nanoform, an innovative drug enabling nanotechnology company, has announced the construction of a GMP manufacturing plant to provide API ‘solution to particle’ nanonization for clinical trials.
Nanoform, a Helsinki, Finland-based drug particle engineering and nanotechnology company, is set to globalize its novel nanonization technology with the appointment of Christian Jones as Chief Commercial Officer.
Nanoform, an innovative drug particle engineering and nanotechnology company that provides novel API particle-size reduction services, is continuing its strategic growth through a significant €7 million investment, with Vator Securities acting as the sole bookrunner.